Evidence map›Paper›PMID 22687643›Full record

ArticleClinica chimica acta; international journal of clinical chemistry2012

Determination of ebselen-sensitive reactive oxygen metabolites (ebROM) in human serum based upon N,N'-diethyl-1,4-phenylenediamine oxidation.

Yongliang Liang, James R Roede, Sergey Dikalov, Nana Gletsu Miller, Samuel C Dudley, Arshed Quyyumi, Dean P Jones

Abstract read
In one paragraph

Article in Clinica chimica acta; international journal of clinical chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yongliang LiangClinical Biomarkers Laboratory, Allergy and Critical Care Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, United States.
James R Roede
Sergey Dikalov
Nana Gletsu Miller
Samuel C Dudley
Arshed Quyyumi
Dean P Jones
Emory University · USPurdue University West Lafayette · USUniversity of Illinois Chicago · USVanderbilt University · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · NCRR · EMORY UNIVERSITY · PI VACCARINO, VIOLA · 1985 to 2007
$21.3M
Vascular specific ACE expression and atherosclerosisP01HL058000 · NHLBI · VANDERBILT UNIVERSITY · PI DIKALOV, SERGEY · 1998 to 2013
$20.7M
Thioredoxin-2 protection against mitochondrial oxidative toxicityR01ES009047 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 1998 to 2013
$3.9M
Na+ channel mRNA splicing in heart failureR01HL104025 · NHLBI · UNIVERSITY OF MINNESOTA · PI DUDLEY, SAMUEL C · 2011 to 2019
$3.3M
Nuclear and Cytoplasmic Redox in Oxidative StressR01ES011195 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2001 to 2011
$3.3M
Metabolic Regulation of Sodium ChannelsR01HL106592 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDLEY, SAMUEL C · 2011 to 2014
$1.6M
Angiotensin converting enzyme, angiotensin II, and arrhythmiaR01HL085558 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDLEY, SAMUEL C · 2007 to 2010
$1.5M
Insulin resistance in severely obese patientsR03DK067167 · NIDDK · EMORY UNIVERSITY · PI GLETSU MILLER, NANA · 2004 to 2006
$450k
Plasma Proteome Profiling of Insulin ResistanceR21DK075745 · NIDDK · EMORY UNIVERSITY · PI GLETSU MILLER, NANA · 2007 to 2008
$417k
A blood test to predict sudden death riskR41HL112355 · NHLBI · ROS TECHNOLOGIES, INC. · PI DUDLEY, SAMUEL C · 2012 to 2012
$270k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS M01 RR000039NCRR NIH HHS RR00039NHLBI NIH HHS P01 HL058000NHLBI NIH HHS R01 HL085558NHLBI NIH HHS R01 HL104025NHLBI NIH HHS R01 HL106592NHLBI NIH HHS R41 HL112355NIDDK NIH HHS DK067167NIDDK NIH HHS DK075745NIDDK NIH HHS R03 DK067167NIDDK NIH HHS R21 DK075745NIEHS NIH HHS ES009047NIEHS NIH HHS ES011195NIEHS NIH HHS R01 ES009047NIEHS NIH HHS R01 ES011195
6 · The paper itself

Abstract

backgroundOxidative stress occurs through free radical- and non-radical-mediated oxidative mechanisms, but these are poorly discriminated by most assays. A convenient assay for oxidants in human serum is based upon the Fe(2+)-dependent decomposition of peroxides to oxidize N,N'-diethyl-1,4-phenylenediamine (DEPPD) to a stable radical cation which can be measured spectrophotometrically.

methodsWe investigated modification of the DEPPD oxidation assay to discriminate color formation due to non-radical oxidants, including hydroperoxides and endoperoxides, which are sensitive to ebselen.

resultsUse of serum, which has been pretreated with ebselen as a reference, provides a quantitative assay for non-radical, reactive oxidant species in serum, including hydroperoxides, endoperoxides and epoxides. In a set of 35 human serum samples, non-radical oxidants largely accounted for DEPPD oxidation in 86% of the samples while the remaining 14% had considerable contribution from other redox-active chemicals.

conclusionsThe simple modification in which ebselen-pretreated sample is used as a reference provides means to quantify non-radical oxidants in human serum. Application of this approach could enhance understanding of the contribution of different types of oxidative stress to disease.

Indexed as

AzolesHumansIsoindolesMolecular StructureOrganoselenium CompoundsOxidation-ReductionOxidative StressOxygenPhenylenediaminesAzolesebselenIsoindolesOrganoselenium CompoundsOxygenPhenylenediamines

Identifiers

PMID22687643
PMCPMC3662006
OpenAlexW2162136024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.